Collar's Insider Trades & SAST Disclosures

Collar's most recent trade in Heron Therapeutics Inc was a trade of 34,789 Common Stock done . Disclosure was reported to the exchange on July 31, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Heron Therapeutics Inc
Craig A. Collard Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jul 2025 34,789 474,538 (0%) 0% - Common Stock
Heron Therapeutics Inc
Craig A. Collard Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jul 2025 34,789 487,042 - - Restricted Stock Units
Heron Therapeutics Inc
Craig A. Collard Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jul 2025 13,797 439,749 (0%) 0% - Common Stock
Heron Therapeutics Inc
Craig A. Collard Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jul 2025 13,797 137,969 - - Restricted Stock Units
HysterYale Materials Handling
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2025 948 4,480 (0%) 0% 0 Class A Common Stock
HysterYale Materials Handling
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2025 638 5,118 (0%) 0% 0 Class A Common Stock
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2025 51 4,658 - - Restricted Stock Units (Deferred Stock Award 2/24/16)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2025 48 4,364 - - Restricted Stock Units (Deferred Stock Award 2/13/20)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2025 45 4,088 - - Restricted Stock Units (Deferred Stock Award 2/18/25)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2025 36 3,292 - - Restricted Stock Units (Deferred Stock Award 2/22/17)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2025 34 3,074 - - Restricted Stock Units (Deferred Stock Award 2/11/21)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2025 34 3,139 - - Restricted Stock Units (Deferred Stock Award 2/20/24)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2025 32 2,889 - - Restricted Stock Units (Deferred Stock Award 2/24/23)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2025 32 2,909 - - Restricted Stock Units (Deferred Stock Award 2/15/18)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2025 32 2,918 - - Restricted Stock Units (Deferred Stock Award 2/14/19)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2025 31 2,839 - - Restricted Stock Units (Deferred Stock Award 2/10/22)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2025 19 1,782 - - Restricted Stock Units (Deferred Stock Award 5/5/15)
Heron Therapeutics Inc
A. Craig Collard Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2025 34,789 425,952 (0%) 0% - Common Stock
Heron Therapeutics Inc
Collard A. Craig Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2025 34,789 521,831 - - Restricted Stock Units
Heron Therapeutics Inc
Craig A. Collard Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Apr 2025 13,796 391,163 (0%) 0% - Common Stock
Heron Therapeutics Inc
Craig A. Collard Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Apr 2025 13,796 151,766 - - Restricted Stock Units
Heron Therapeutics Inc
Craig A. Collard Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Apr 2025 62,500 377,367 (0%) 0% - Common Stock
Heron Therapeutics Inc
Craig A. Collard Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Apr 2025 62,500 125,000 - - Restricted Stock Units
HysterYale Materials Handling
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2025 755 3,024 (0%) 0% 0 Class A Common Stock
HysterYale Materials Handling
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2025 508 3,532 (0%) 0% 0 Class A Common Stock
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 42 4,607 - - Restricted Stock Units (Deferred Stock Award 2/24/16)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 39 4,316 - - Restricted Stock Units (Deferred Stock Award 2/13/20)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 37 4,043 - - Restricted Stock Units (Deferred Stock Award 2/18/25)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 30 3,256 - - Restricted Stock Units (Deferred Stock Award 2/22/17)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 28 3,040 - - Restricted Stock Units (Deferred Stock Award 2/11/21)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 28 3,105 - - Restricted Stock Units (Deferred Stock Award 2/20/24)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 26 2,886 - - Restricted Stock Units (Deferred Stock Award 2/14/19)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 26 2,877 - - Restricted Stock Units (Deferred Stock Award 2/15/18)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 26 2,857 - - Restricted Stock Units (Deferred Stock Award 2/24/23)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 25 2,808 - - Restricted Stock Units (Deferred Stock Award 2/10/22)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 16 1,763 - - Restricted Stock Units (Deferred Stock Award 5/5/15)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2025 4,006 4,006 - - Restricted Stock Units (Deferred Stock Award 2/18/25)
Heron Therapeutics Inc
Craig A. Collard Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 1,113,240 1,113,240 - - Employee Stock Option (Right to Buy)
Heron Therapeutics Inc
Craig A. Collard Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 556,620 556,620 - - Restricted Stock Units
Heron Therapeutics Inc
Craig A. Collard Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jan 2025 13,797 314,867 (0%) 0% - Common Stock
Heron Therapeutics Inc
Craig A. Collard Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jan 2025 13,797 165,562 - - Restricted Stock Units
HysterYale Materials Handling
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 620 1,858 (0%) 0% 0 Class A Common Stock
HysterYale Materials Handling
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 411 2,269 (0%) 0% 0 Class A Common Stock
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2024 33 4,565 - - Restricted Stock Units (Deferred Stock Award 2/24/16)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2024 31 4,277 - - Restricted Stock Units (Deferred Stock Award 2/13/20)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2024 23 3,226 - - Restricted Stock Units (Deferred Stock Award 2/22/17)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2024 22 3,077 - - Restricted Stock Units (Deferred Stock Award 2/20/24)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2024 21 3,012 - - Restricted Stock Units (Deferred Stock Award 2/11/21)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2024 20 2,851 - - Restricted Stock Units (Deferred Stock Award 2/15/18)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2024 20 2,860 - - Restricted Stock Units (Deferred Stock Award 2/14/19)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2024 20 2,831 - - Restricted Stock Units (Deferred Stock Award 2/24/23)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2024 20 2,783 - - Restricted Stock Units (Deferred Stock Award 2/10/22)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2024 12 1,747 - - Restricted Stock Units (Deferred Stock Award 5/5/15)
Heron Therapeutics Inc
Craig A. Collard Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Oct 2024 13,797 290,387 (0%) 0% - Common Stock
Heron Therapeutics Inc
Craig A. Collard Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Oct 2024 13,797 179,359 - - Restricted Stock Units
HysterYale Materials Handling
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2024 557 870 (0%) 0% 0 Class A Common Stock
HysterYale Materials Handling
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2024 368 1,238 (0%) 0% 0 Class A Common Stock
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2024 35 4,532 - - Restricted Stock Units (Deferred Stock Award 2/24/16)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2024 33 4,246 - - Restricted Stock Units (Deferred Stock Award 2/13/20)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2024 25 3,203 - - Restricted Stock Units (Deferred Stock Award 2/22/17)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2024 24 3,055 - - Restricted Stock Units (Deferred Stock Award 2/20/2024)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2024 23 2,991 - - Restricted Stock Units (Deferred Stock Award 2/11/21)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2024 22 2,831 - - Restricted Stock Units (Deferred Stock Award 2/15/18)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2024 22 2,840 - - Restricted Stock Units (Deferred Stock Award 2/14/19)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2024 22 2,811 - - Restricted Stock Units (Deferred Stock Award 2/24/23)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2024 21 2,763 - - Restricted Stock Units (Deferred Stock Award 2/10/22)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2024 13 1,735 - - Restricted Stock Units (Deferred Stock Award 5/5/15)
Heron Therapeutics Inc
Craig A. Collard Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jul 2024 13,797 193,156 - - Restricted Stock Units
Heron Therapeutics Inc
Craig A. Collard Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jul 2024 13,797 276,590 (0%) 0% - Common Stock
HysterYale Materials Handling
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2024 313 313 (0%) 0% 0 Class A Common Stock
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2024 24 4,497 - - Restricted Stock Units (Deferred Stock Award 2/24/16)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2024 23 4,213 - - Restricted Stock Units (Deferred Stock Award 2/13/20)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2024 17 3,178 - - Restricted Stock Units (Deferred Stock Award 2/22/17)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2024 16 3,031 - - Restricted Stock Units (Deferred Stock Award 2/20/2024)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2024 16 2,968 - - Restricted Stock Units (Deferred Stock Award 2/11/21)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2024 15 2,809 - - Restricted Stock Units (Deferred Stock Award 2/15/18)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2024 15 2,818 - - Restricted Stock Units (Deferred Stock Award 2/14/19)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2024 15 2,789 - - Restricted Stock Units (Deferred Stock Award 2/24/23)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2024 15 2,742 - - Restricted Stock Units (Deferred Stock Award 2/10/22)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2024 9 1,722 - - Restricted Stock Units (Deferred Stock Award 5/5/15)
Blend Labs Inc Ordinary
Erin James Collard Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2024 27,760 0 - - Restricted Stock Units
Blend Labs Inc Ordinary
Erin James Collard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2024 27,760 27,760 - - Restricted Stock Units
Blend Labs Inc Ordinary
Erin James Collard Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2024 27,760 1,091,986 - - Class A Common Stock
Heron Therapeutics Inc
Craig A. Collard Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Apr 2024 13,797 262,793 (0%) 0% - Common Stock
Heron Therapeutics Inc
Craig A. Collard Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Apr 2024 13,797 206,953 - - Restricted Stock Units
Heron Therapeutics Inc
Craig A. Collard Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Apr 2024 62,500 248,996 (0%) 0% - Common Stock
Heron Therapeutics Inc
Craig A. Collard Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Apr 2024 62,500 187,500 - - Restricted Stock Units
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2024 19 4,473 - - Restricted Stock Units (Deferred Stock Award 2/24/16)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2024 18 4,190 - - Restricted Stock Units (Deferred Stock Award 2/13/20)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2024 13 3,161 - - Restricted Stock Units (Deferred Stock Award 2/22/17)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2024 13 2,952 - - Restricted Stock Units (Deferred Stock Award 2/11/21)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2024 13 3,015 - - Restricted Stock Units (Deferred Stock Award 2/20/2024)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2024 12 2,794 - - Restricted Stock Units (Deferred Stock Award 2/15/18)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2024 12 2,803 - - Restricted Stock Units (Deferred Stock Award 2/14/19)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2024 12 2,727 - - Restricted Stock Units (Deferred Stock Award 2/10/22)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2024 12 2,774 - - Restricted Stock Units (Deferred Stock Award 2/24/23)
Hillenbrand Inc
Gary L. Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2024 7 1,713 - - Restricted Stock Units (Deferred Stock Award 5/5/15)
Hillenbrand Inc
Collar Gary L. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2024 3,002 3,002 - - Restricted Stock Units (Deferred Stock Award 2/20/2024)
Heron Therapeutics Inc
A. Craig Collard Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 1,324,502 1,324,502 - - Employee Stock Option (Right to Buy)
Heron Therapeutics Inc
Craig A. Collard Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 220,750 220,750 - - Restricted Stock Units
Hillenbrand Inc
L. Gary Collar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Dec 2023 20 4,454 - - Restricted Stock Units (Deferred Stock Award 2/24/16)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades